Overview

Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

Status:
NOT_YET_RECRUITING

Trial end date:
2027-12-10

Target enrollment:

Participant gender:

Summary

To assess the safety, feasibility and preliminary efficacy of ketamine-enhanced therapy (KET) for alcohol use disorder (AUD) and comorbid major depressive disorder (MDD) in an open-label, single arm, pilot clinical trial.

Phase:

PHASE1

Details

Lead Sponsor:

South West Sydney Local Health District

Collaborator:

The University of Sydney, Sydney, Australia

Treatments:

Cognitive Behavioral Therapy
Ketamine
Psychotherapy